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Germinal centers (GCs) are organized as discrete, tightly 
confined clusters of GC B cells and T follicular helper cells 
(Tfh cells) in the center of reactive (secondary) follicles. 
Confinement of GC B cells to the GC is important for 
fostering interactions with antigen-loaded follicular DCs 
(FDCs) and Tfh cells during the selection events necessary 
for antibody affinity maturation (Victora and Nussenzweig, 
2012). The sphingosine-1-phosphate receptor S1pr2 is a G 
protein–coupled receptor (GPCR) that is highly up-regulated 
on GC B cells and signals via the G protein Gα13 and the 
RhoGEF Arhgef1 (also known as p115 RhoGEF or Lsc) 
to inhibit cell migration in response to chemoattractants 
(Green et al., 2011; Muppidi et al., 2014). S1P is abundant 
in lymph and blood, rapidly degraded in interstitial fluids 
by the action of membrane phosphatases and an intracellu-
lar lyase, and thought to exist in a decaying gradient from 
the outer to the center follicle (Green et al., 2011; Cyster 
and Schwab, 2012). S1pr2 promotes GC B cell and Tfh cell 
confinement to the follicle center, most likely by inhibit-
ing migration into regions of high S1P (Green et al., 2011; 
Moriyama et al., 2014; Muppidi et al., 2014). Maintenance 
of the follicular S1P gradient appears to occur in the ab-
sence of FDCs (Wang et al., 2011). However, S1pr2 defi-
ciency does not lead to a complete dispersal of GC B cells 
or to their appearance in circulation, suggesting that addi-
tional factors act to promote GC B cell confinement.
Deficiency in Gα13 and Arhgef1 in the mouse is also 
associated with loss of local GC B cell confinement, and these 
deficiencies lead to appearance of GC B cells in lymph and 
blood (Muppidi et al., 2014). The more penetrant effect of 
Gα13 deficiency than S1pr2 deficiency led us to identify a 
second human receptor, P2RY8, that can act via Gα13 to 
promote B cell association with GCs (Muppidi et al., 2014). 
Although human P2RY8 is active when expressed in the 
mouse, the P2RY8 gene is located on a portion of the pseu-
doautosomal region of the X chromosome that is lost in ro-
dents, and no orthologues have been identified in the mouse. 
Because Gα13 signaling in B cells inhibits migration, the 
GC clustering activity of P2RY8 suggests that the P2RY8 
ligand might, like S1P, be more abundant in the outer fol-
licle than in the follicle center. Although the identity of the 
P2RY8 ligand is unknown, in this study, we take advantage 
of the ability of P2RY8 overexpression to direct cell move-
ments in the mouse to dissect cellular requirements for con-
trolling ligand distribution.
Loss of function mutations of S1PR2, P2RY8, GNA13 
(encoding Gα13), and ARH GEF1 are frequently found in 
human lymphomas derived from GC B cells (GC B cell–like 
diffuse large B cell lymphoma [GCB-DLB CL] and Burkitt 
lymphoma [BL]; Morin et al., 2011; Lohr et al., 2012; Schmitz 
et al., 2012; Muppidi et al., 2014). These malignancies are 
considered systemic diseases in humans, and spread of the 
malignant GC B cells to distant sites such as BM is associated 
with poor prognosis (Sehn et al., 2011). It is currently unclear 
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whether Gα13 deficiency itself is sufficient to promote GC 
B cell egress or whether loss of Gα13 signaling allows other 
promigratory signals to dominate and promote egress.
In this study, we sought to further define how GC B cells 
are normally confined to the GC niche and to understand 
how GC B cells carrying mutations typical of GC lympho-
mas undergo systemic spread. We demonstrate that FDCs are 
required for the function of human P2RY8 in promoting cell 
clustering at the center of mouse lymphoid follicles. Although 
P2RY8 is not present in the mouse, we find that FDCs act 
via a Gα13-dependent mechanism to promote clustering of 
mouse GC B cells and prevent their egress into lymph. Finally, 
we show that egress of Gα13-deficient mouse GC B cells is 
promoted by the promigratory S1P receptor S1pr3.
RES ULTS AND DIS CUSSI ON
FDCs are required for P2RY8-mediated GC confinement
We took advantage of our finding that human P2RY8 is ac-
tive when expressed in the mouse to determine the cell types 
that influence ligand distribution in vivo and allow P2RY8 
to function. Retroviral transduction of P2RY8 in activated 
mouse B cells caused cells to position in and around GCs 
after transfer into SRBC-immunized hosts in contrast to 
control-transduced B cells, which were evenly distributed 
throughout the follicle and excluded from GCs (Fig.  1  A; 
Muppidi et al., 2014). When P2RY8-transduced B cells were 
found in the GC, they appeared to be preferentially posi-
tioned in the light zone (LZ) near FDCs (Fig. 1 B and not 
depicted). To test whether a preexisting GC was required 
for P2RY8-dependent positioning at the center of the fol-
licle, we transferred vector- or P2RY8-transduced activated 
B cells into CD19-deficient animals that lack splenic GCs 
(Rickert et al., 1995). Lack of GL7 staining confirmed an ab-
sence of GCs in CD19-deficient animals (Fig. 1 B). Primary 
follicle FDCs, however, appeared normal in distribution, as 
seen by CD35 staining (Fig.  1  B). In the absence of GCs, 
P2RY8 overexpression was able to cause B cells to be posi-
tioned at the center of the follicle, over the FDC network, 
whereas vector-transduced B cells were positioned evenly 
throughout the follicle (Fig. 1 B). Much smaller numbers of 
P2RY8-transduced cells could also be seen in the marginal 
zone and T zone. These findings established that the GC it-
self was not required for P2RY8-mediated guidance to the 
follicle center. Given that P2RY8-transduced cells appeared 
to preferentially position near FDCs in both primary follicles 
and in GCs, we hypothesized that FDCs were required for 
P2RY8-mediated follicle center confinement.
Lymphotoxin (LT) signaling is required for FDC sur-
vival, and one effect of short-term LT blockade is loss of 
FDCs (Mackay et al., 1997). We transferred vector- or 
P2RY8-transduced activated B cells into hosts that had been 
treated for 1 wk with LTβ receptor fused to human IgG Fc 
(LTβR-Fc) to block LT signaling or with human IgG as a 
control. Whereas LT blockade had little effect on positioning 
of vector-transduced B cells, P2RY8-mediated clustering of 
B cells at the follicle center was nearly completely disrupted 
and P2RY8-transduced cells were found scattered with the 
endogenous B cells and in the T zone (Fig. 1 C). As a sec-
ond test of the FDC requirement, we generated BM chime-
ras using hosts that expressed cre-recombinase under control 
of the CD21 promoter (CD21-cre) and the diphtheria toxin 
(DTx) receptor (DTR) downstream of a floxed stop element 
in the ROSA26 locus (CD21-DTR mice; Wang et al., 2011). 
In these BM chimeras, the DTR is expressed in nonhema-
topoietic CD21-expressing cells. Recent work has shown 
that, in addition to FDCs, CD21-cre is expressed in a fur-
ther population of stromal cells termed “versatile stromal cells 
(VSCs)” that can take on FDC characteristics in inflamed 
peripheral LNs (Jarjour et al., 2014). In unimmunized mice, 
VSCs are situated in the T zone, limiting the follicular effect 
of DTx-mediated cell ablation to loss of FDCs. P2RY8- or 
vector-transduced B cells were transferred into control or 
CD21-DTR reverse BM chimeras that were then treated for 
1 d with DTx. Acute FDC ablation prevented P2RY8-medi-
ated clustering at the center of the follicle (Fig. 1 D).
Unimmunized Cxcl13-deficient mice lack FDCs as the 
result of low expression of surface LTα1β2 on naive B cells 
(Ansel et al., 2000). After immunization, LT expression by GC 
B cells can drive FDC development in the absence of Cxcl13, 
although these FDCs are small and misplaced. To determine 
whether ectopic FDCs could drive P2RY8-dependent cellu-
lar clustering, we transferred vector- or P2RY8-transduced 
B cells into immunized Cxcl13-deficient mice. In the ab-
sence of Cxcl13, ectopic FDCs were sufficient to promote 
P2RY8-dependent B cell clustering (Fig. 1 E).
Collectively, these data show that FDCs are necessary 
and sufficient for P2RY8-dependent positioning of B cells in 
the GC niche. Given that P2RY8 is a Gα13-coupled receptor 
(Muppidi et al., 2014) and Gα13-coupled receptors are mi-
gration inhibitory in B cells, we predict that the P2RY8 ligand 
is high in the outer follicle and low in the center of follicle, 
possibly because of ligand degradation or lack of ligand pro-
duction by FDCs. Our positioning experiments also predict 
that the P2RY8 ligand is low in marginal zone and T zone.
In addition to containing B cells, GC LZs contain Tfh 
cells. Tfh cells in the GC express high levels of Bcl6 and 
CXCR5 (GC-Tfh), in contrast to Tfh cells outside the GC 
that express intermediate levels of both Bcl6 and CXCR5 
(pre-GC Tfh; Crotty, 2011). By quantitative PCR (qPCR) 
analysis, P2RY8 was strongly up-regulated in CXCR5-high 
CD4+ T cells from human tonsil but not CXCR5-interme-
diate or CXCR5− CD4+ T cells (Fig.  1  F). In contrast to 
findings for Tfh cells associated with primary GC responses 
in mouse LNs (Moriyama et al., 2014), human tonsil GC-
Tfh did not up-regulate S1PR2 (Fig.  1  F). Tonsil GCs are 
thought to be chronically stimulated, and in this regard, it 
is notable that Tfh cells associated with secondary GCs in 
the mouse have a different gene expression profile compared 
with those associated with primary GCs, including somewhat 
lower S1pr2 expression (Suan et al., 2015). We speculate that 
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Figure 1. FDCs are required for P2RY8-dependent confinement to the center of the follicle. (A–E) Activated Gpr183+/− B cells (see Materials and 
methods) were transduced with retroviral vector encoding Thy1.1 alone (vector) or P2RY8 and Thy1.1 and transferred into WT animals previously immunized 
with sheep red blood cells (SRBC; A), CD19-deficient animals lacking splenic GCs (B), WT animals treated with LTβR-Fc or human IgG for 1 wk (C), CD21-
DTR or littermate control reverse BM chimeras treated with DTx at the time of transfer (D), or previously immunized Cxcl13−/− animals (E, arrows indicate 
ectopic FDC; two images are shown for each condition). Spleens were harvested 1 d after transfer and analyzed immunohistochemically for the presence 
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P2RY8 may have a prominent and nonredundant role in Tfh 
cell positioning in LZs of chronically stimulated human GCs.
FDCs prevent dispersal and egress of GC B cells via Gα13
Although a P2RY8 orthologue does not exist in the mouse, 
our past work established that mouse S1pr2 deficiency does 
not phenocopy Gα13 deficiency in terms of egress of GC B 
cells into circulation (Muppidi et al., 2014). This suggested 
that an additional cue, possibly related to the ones acting via 
P2RY8, functions in the mouse to promote confinement of 
GC B cells via Gα13. Consistent with this logic, previous 
work from our laboratory suggested that S1pr2 cooperated 
with FDCs to promote confinement of GC B cells within 
follicles in mesenteric LNs (mLNs; Wang et al., 2011). To ad-
dress the role of FDCs in promoting mouse GC B cell con-
finement and in preventing egress of GC B cells into lymph, 
we tested the effect of FDC ablation using CD21-DTR re-
verse BM chimeras. DTx treatment of CD21-DTR reverse 
BM chimeras results in a rapid reduction in GC B cells, likely 
as a result of the loss of prosurvival factors provided by FDCs 
to GC B cells (Wang et al., 2011). Therefore, to assess the role 
of FDCs in GC confinement and to reduce the influence of 
loss of these prosurvival cues, we generated littermate control 
and CD21-DTR reverse BM chimeras using BCL2-tg BM 
in which BCL2 is overexpressed in B cells. FDC ablation in 
these chimeras led to minimal change in mLN GC B cell 
numbers, and it did not lead to an increase in GC B cells in 
lymph (Fig. 2 A). Immunohistochemical analysis showed that 
GC B cells in the DTx-treated mice remained confined to 
their niche at the follicle center despite the absence of FDCs 
(Fig. 2 B). To quantify GC B cell dispersal, we developed an 
algorithm to calculate the area within a follicle where GC 
B cells were intermixed with naive follicular B cells in im-
munohistochemical images (see Materials and methods and 
Fig. S1 A). We defined the GC dispersal index as the area 
within the follicle where IgD and GL7 staining were inter-
mixed. This measure was very consistent across a number 
GCs of varying sizes from mLNs of WT animals such that 
confined GCs typically have a GC dispersal index of 0.18 
(Fig. S1, B and C). When we applied this algorithm to con-
trol and FDC-ablated BCL2-tg BM chimeras, we found that 
after FDC ablation, there was no loss of GC confinement 
(Fig. 2 B, right; and Fig. S1 D). These observations are consis-
tent with S1pr2 being able to act as a confinement receptor 
even in the absence of FDCs.
S1pr2-deficient GC B cells have enhanced survival 
compared with WT cells (Green et al., 2011) and they are 
also resilient to loss after FDC ablation (Fig. 2 C, left; Wang 
et al., 2011). However, in contrast to the findings in BCL2-tg 
chimeras, the S1pr2-deficient GC B cells became dispersed 
throughout the mLNs after FDC ablation (Fig. 2 D and Fig. 
S1 E). Importantly, FDC ablation also promoted the egress of 
S1pr2-deficient GC B cells into lymph (Fig. 2 C, right). To 
determine whether egress of S1pr2-deficient GC B cells into 
lymph after FDC ablation was caused by loss of an additional 
input into Gα13 in GC B cells, we reconstituted lethally ir-
radiated control or CD21-DTR reverse BM chimeras using 
BM from mice with a B cell–specific deletion of Gna13. 
In the control BM chimeras there was already dispersal of 
GC B cells through the follicles and appearance of signifi-
cant numbers of GC B cells in lymph (Fig. 2, E and F; and 
Fig. S1 F), consistent with our earlier data (Muppidi et al., 
2014). Importantly, FDC ablation did not result in greater dis-
persal of Gα13-deficient GC B cells histologically (Fig. 2 F 
and Fig. S1 F) or to greater dissemination of Gα13-defi-
cient GC B cells into lymph (Fig. 2 E). These data suggest 
that FDCs cooperate with S1pr2 to promote follicle center 
confinement and prevent egress of mouse GC B cells via a 
Gα13-dependent mechanism.
Egress of Gα13-deficient GC B cells into 
circulation is mediated by S1pr3
It was unclear whether the loss of Gα13 signaling itself was 
sufficient to drive GC B cells into circulation or whether the 
loss of Gα13 allowed other promigratory cues in GC B cells 
to dominate and thereby promote egress. In considering this 
issue, we noted that the disruption of GC architecture in the 
absence of Gα13 sometimes appeared most evident in GCs 
that were closest to the LN capsule, with extensive spreading 
of GC B cells throughout the follicle (Fig. 3 A, arrows and 
inset). This led us to speculate that a factor that was abun-
dant in lymphatic sinuses was promoting a greater degree of 
spreading of GC B cells in follicles, and possibly egress of GC 
B cells from the mLN into circulation.
Previous work has established that S1P concentrations 
are high in lymph and blood and are much lower within lym-
phoid tissue. We hypothesized that S1P could be present in 
higher amounts in follicles near lymph-filled subcapsular and 
cortical sinuses (Cyster and Schwab, 2012). We have previ-
ously shown in vitro that S1P inhibits chemokine-induced 
migration of WT GC B cells via the action of S1pr2 and 
Gα13, and it cannot induce their migration even when used 
at high concentrations that efficiently promote migration of 
other lymphocyte populations (Green et al., 2011; Muppidi 
et al., 2014). Paradoxically, in the absence of Gα13 or Arhgef1, 
S1P became promigratory for GC B cells (Fig. 3 B and not 
depicted). Several S1P receptors have been shown to promote 
migration toward S1P (Cyster and Schwab, 2012). S1pr1 (also 
of transduced cells (Thy1.1), FDCs (CD35), GC B cells (GL7), or naive follicular B cells (IgD) as indicated. Bars, 100 µm. Images are representative of four, 
two, two, two, and three independent experiments, respectively. (F) qPCR of S1PR2, P2RY8, and BCL6 from CXCR5− (non-Tfh), CXCR5 intermediate (pre-GC 
Tfh), and CXCR5-high (GC Tfh) CD4+ T cells from human tonsil. Data are from four donors and lines indicate means. **, P < 0.01; ***, P < 0.001, unpaired 
two-tailed Student’s t test.
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known as S1P1 or Edg1) is the best characterized of these 
promigratory S1P receptors. However, unlike naive follicular 
B cells that express high levels of S1pr1 and migrate toward 
S1P in an S1pr1-dependent fashion, S1pr1 is transcription-
ally down-regulated in GC B cells (Green et al., 2011). To 
exclude the possibility that low-level S1pr1 expression was 
sufficient to promote egress of GC B cells into circulation, 
we treated Arhgef1-deficient mixed BM chimeras with the 
S1pr1 functional antagonist, FTY720, and assessed lymph for 
the presence of GC B cells. As expected, given the known 
role of S1pr1 in promoting egress of follicular B cells into cir-
culation (Matloubian et al., 2004), there was a large reduction 
Figure 2. FDCs cooperate with S1pr2 to promote Gα13-dependent confinement of mLN GC B cells. (A–F) CD21-DTR or control mice were reconsti-
tuted with BCL2-tg (A and B), S1pr2−/− (C and D), or Gna13 KO (f/f mb1-cre; E and F) BM. Chimeras were treated with 100 ng DTx i.p., and 16–20 h later the 
frequency of GC B cells in mLNs and lymph was analyzed by FACS (A, C, and E) or mLNs were analyzed immunohistochemically (B, D, and F) for the presence 
of GC B cells (GL7, top) or FDCs (CD35, bottom). Bars, 100 µm. The GC dispersal index was calculated within individual follicles by analyzing the area of the 
follicle with intermixing of GL7 and IgD stains (see Materials and methods and Fig. S1). A, C, and E are pooled data from two, four, and two independent 
experiments, respectively, with two to four mice per group in each experiment. Images in B, D, and F are representative of two, three, and two mice of each 
type, respectively. In dot plots in A, C, and E, dots indicate individual mice and lines indicate means. In dot plots in B, D, and F, dots indicate the GC dispersal 
index within an individual follicle and lines indicate means. **, P < 0.01, unpaired two-tailed Student’s t test.
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Figure 3. S1pr3 is required for egress of Gα13-deficient GC B cells into circulation. (A) Immunohistochemical analysis of mLNs from Gna13 WT 
(f/+) or KO (f/f mb1-cre) animals stained to detect GC B cells (GL7) and naive follicular B cells (IgD). Arrows indicate subcapsular GCs with greatest degree 
of dispersal. Black boxes indicate GC shown in enlarged image to the right. Data are representative of at least four animals of each type. (B) Transwell mi-
gration of Arhgef1 WT or KO GC B cells to 100 ng/ml CXCL12 in the presence or absence of S1P, or to S1P alone, at the indicated concentrations. Shown are 
pooled data from four independent experiments. (C) Lymph was collected from Arhgef1 mixed chimeras treated with 1 mg/kg FTY720 or saline i.p. for 3 h 
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in the number of both Arhgef1-deficient and CD45.1 WT 
follicular B cells in lymph after FTY720 treatment (Fig. 3 C, 
left). However, the number of Arhgef1-deficient GC B cells 
in lymph after FTY720 was only slightly decreased (Fig. 3 C, 
right), suggesting that S1pr1 is not principally responsible for 
egress of Gα13- or Arhgef1-deficient GC B cells.
S1pr3, a second S1P receptor that can couple to Gαi 
and have promigratory effects (Cinamon et al., 2004), is 
up-regulated on mouse GC B cells relative to follicular B 
cells (Fig.  3  D). In agreement with studies comparing ge-
nome-wide LZ and dark zone (DZ) GC B cell gene ex-
pression (Victora et al., 2010; unpublished data), S1pr3 is 
up-regulated on LZ relative to DZ GC B cells (Fig.  3 D). 
Consistent with the possibility that S1pr3 promotes egress of 
mouse Gα13- or Arhgef1-deficient GC B cells into circula-
tion, we found that the majority of Gα13- or Arhgef1-de-
ficient GC B cells in lymph from mixed chimeras were LZ 
phenotype (Fig. 3 E). To determine whether S1pr3 supported 
migration of Gα13-deficient GC B cells toward S1P, we gen-
erated B cell–specific Gα13-deficient mice that were also de-
ficient for S1pr3. In the absence of S1pr3, Gα13-deficient 
GC B cells could not migrate toward S1P, and cells lacking 
one copy of S1pr3 showed an intermediate defect in their 
migratory response (Fig. 3 F). Histologically, Gα13-deficient 
GC B cells demonstrated a partial rescue in their confine-
ment when they also lacked S1pr3 (Fig. 3 G). Histological 
quantification of multiple follicles showed a wide range of 
GC dispersal in the absence of Gα13 that was reduced by the 
additional absence of S1pr3 (Fig. 3 G, right; and Fig. S1 G). 
In mixed BM chimeras Gα13/S1pr3 double-deficient GC 
B cells outgrew their WT counterparts to a similar extent as 
Gα13 single-deficient GC B cells (Fig. 3 H). However, when 
we examined circulatory fluids of these mixed chimeras, we 
found that loss of S1pr3 was sufficient to prevent egress of 
Gα13-deficient GC B cells into lymph and blood (Fig. 3 I). 
Although in the absence of one copy of S1pr3 there was only 
a small nonstatistically significant reduction in GC dispersal 
histologically, S1pr3 heterozygosity led to a significant reduc-
tion in GC B cell appearance in lymph (Fig.  3, G [right] 
and I). Previous studies have established that under conditions 
when cells are responding to multiple opposing promigratory 
inputs, heterozygosity in chemoattractant receptor expression 
can have a strong impact on the response (Cinamon et al., 
2004; Ekland et al., 2004; Pham et al., 2008; Meechan et al., 
2012; McDermott et al., 2015). These data provide evidence 
that in the absence of Gα13 signaling, S1P acts via S1pr3 to 
promote the egress of mouse GC B cells into circulation.
Concluding remarks
In summary, we find that FDCs promote confinement of B 
cells to the GC niche via a Gα13-dependent mechanism. Our 
studies suggest that in humans this involves P2RY8, whereas 
in mouse the nature of the Gα13-coupled receptor involved 
is not yet defined. We speculate that although mice lack a 
P2RY8 orthologue, the same conserved ligand acts on the 
unidentified mouse receptor to promote Gα13 signaling 
in GC B cells. We suggest a model in which a broadly dis-
tributed small molecule GPCR ligand is degraded or inac-
tivated by FDCs, causing these cells to act as a “sink” and 
make the follicle center a low point in the ligand field, al-
lowing the migration-inhibitory Gα13-coupled receptor to 
promote confinement of cells to this region. The EBI2 ligand 
7α,25-dihydroxycholesterol (7α,25-HC) provides precedent 
for a GPCR ligand being abundant at the outer follicle and 
being maintained in low abundance in the follicle center in 
an FDC-dependent manner (Yi et al., 2012). P2RY8 does 
not show migration inhibition by 7α,25-HC, and the abil-
ity of this receptor to promote follicle center clustering of 
B cells was not interrupted in Cyp7b1-deficient mice that 
lack 7α,25-HC (unpublished data). We suggest that another 
small molecule is similarly distributed through related mech-
anisms. Although our and most published studies show that 
Gα13-coupled receptors mediate migration inhibition, rare 
examples of Gα13 having a promigratory role have been re-
ported in fibroblasts and epithelial cells (Shan et al., 2006; 
Yagi et al., 2011), and we cannot exclude the possibility 
that P2RY8 has a promigratory role and that FDCs are a 
source of P2RY8 attractant.
We also show that LN egress of Gα13-deficient mouse 
GC B cells occurs via the up-regulation of S1pr3 on LZ cells. 
We suggest a model in which S1P-S1pr2 signaling in GC 
B cells via Gα13 and Arhgef1 normally dominates the S1P 
response of GC B cells and helps mediate their GC con-
finement. However, when this migration-inhibitory signal-
ing pathway is lacking, S1pr3 can dominate the S1P response 
and allow cells that have entered the follicle to be guided 
and analyzed for the presence of follicular (FoB) or GC B cells. Data are from one experiment representative of two. (D) qPCR of S1pr3 in sorted FoB, total 
GC B, LZ GC B, and DZ GC B. Shown are pooled data from three independent experiments. (E) mLNs or lymph from Arhgef1 or Gna13 KO mixed chimeras 
were analyzed by FACS for the presence of LZ phenotype GC B cells. Left panels show example FACS plots, and the right panel summarizes data from three 
experiments. (F) Transwell migration of Gna13 KO GC B cells that were WT, heterozygous, or deficient for S1pr3. Assay was performed as in B. Shown are 
pooled data from five independent experiments. (G) Immunohistochemical analysis of mLNs from Gna13 KO S1pr3 WT, heterozygous, or KO animals, stained 
as in A. Data are representative of three mice of each type. GC dispersal index of individual follicles was calculated as described in Materials and methods 
and Fig. S1. Bars: (A, whole LNs) 500 µm; (A [enlarged GCs] and G) 100 µm. (H and I) Percentages of GC B cells from mLN (H) lymph or blood (I) from mixed 
BM chimeras that were reconstituted with ∼60% WT CD45.1 and ∼40% Gna13 KO BM that was also WT, heterozygous, or deficient for S1pr3. Data are 
pooled from three independent experiments. In dot plots in C–E, H, and I, dots indicate individual mice and lines indicate means. In the dot plot in G, dots 
indicate the GC dispersal index in individual follicles and lines indicate means. In B and F, error bars show SD. *, P < 0.05; **, P < 0.01; ***, P < 0.001, unpaired 
two-tailed Student’s t test.
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into subcapsular or cortical sinuses for LN egress. Although 
S1PR3 is not up-regulated in human tonsillar GC B cells 
(Victora et al., 2012; unpublished data), we speculate that a 
similar egress-promoting receptor is required for egress of 
GNA13 or ARH GEF1 mutant human GC B cells. Identifi-
cation of this human receptor may provide opportunities to 
inhibit the dissemination of GCB-DLB CL or BL cells.
Efficient selection of high-affinity clones in the GC re-
quires transitioning of cells between the LZ and DZ. CXCR5 
and CXCR4 are the dominant chemotactic inputs mediating 
transition between these two zones (Allen et al., 2004; Ban-
nard et al., 2013). In initial experiments, we have not observed 
defects in LZ positioning of S1pr3-deficient GC B cells (un-
published data), consistent with S1pr2 dominating the S1P 
response of these cells. However, the G protein–coupling 
properties of S1pr3 are complex (Sanchez and Hla, 2004), 
and conditions may exist where S1pr3 can dominate over 
S1pr2 even in WT cells. It will be important to investigate 
whether S1pr3 is required for optimal function of the GC in 
supporting selection of high-affinity clones.
In addition to the P2RY8 mutations we and others 
have previously reported in GC-derived malignancy (Lohr 
et al., 2012; Schmitz et al., 2012; Muppidi et al., 2014), whole 
exome sequencing experiments have reported deleterious 
P2RY8 mutations in gastric, colon, and lung adenocarcino-
mas (Bamford et al., 2004). Therefore, our findings regarding 
cellular requirements for determining P2RY8 ligand distri-
bution may be of broader relevance to understanding how 
P2RY8 loss-of-function contributes to cancer progression.
MAT ERIALS AND MET HODS
Mice and BM chimeras. Adult C57BL6 CD45.1+ (stock 
number 564) mice at least 7 wk of age were from the Na-
tional Cancer Institute (NCI) or NCI at CRV. Gpr183+/−, 
Cd19−/−, Cxcl13−/−, and Arhgef1−/− mice were on a B6 
background. CD21-cre (Cr2-cre) and ROSA-DTR mice 
were on a B6 background and were from The Jackson Labo-
ratory. S1pr3−/− mice were on a B6 background, and S1pr2−/− 
mice (Kono et al., 2004) were backcrossed for at least six 
generations to B6 and were provided by R. Proia (National 
Institue of Diabetes and Digestive and Kidney Diseases, 
Bethesda, MD). Gna13f/f mice were on a mixed C57BL6/129 
background (Ruppel et al., 2005) and were provided by S. 
Coughlin (University of California, San Francisco). Mb1-cre 
mice (provided by M. Reth, Max Planck Institute of Immu-
nobiology and Epigenetics, Freiburg, Germany) express Cre 
in all B lineage cells (Hobeika et al., 2006). BCL2-tg mice 
overexpress BCL2 selectively in B cells (Strasser et al., 1991). 
Mixed BM chimeras were made using Ly5.2 (CD45.1+) from 
NCI as hosts as described previously (Green et al., 2011) and 
analyzed at least 6 wk after reconstitution. Mice were housed 
in a specific pathogen–free environment in the Laboratory 
Animal Research Center at the University of California, San 
Francisco, and all animal procedures were approved by the 
Institutional Animal Care and Use Committee.
Treatments. For LT-blocking experiments, animals were 
treated with LTβR-Fc (provided by J. Browning, Biogen Idec) 
using 100 µg on days −7 and −4 before transfer of transduced 
B cells. FDC ablation was performed as described previously 
(Wang et al., 2011). In brief, animals expressing CD21-cre 
and ROSA-DTR alleles or littermate controls were lethally 
irradiated and reconstituted with WT, BCL2-Tg, S1pr2−/−, or 
mb1-cre Gna13f/f BM. 6–8 wk after irradiation, animals were 
treated with 100 ng DTx (EMD Biosciences) i.p. and ana-
lyzed 16–20 h later. Cxcl13−/− mice were immunized with 
50 µg duck egg lysozyme–ovalbumin in the Sigma-Aldrich 
Adjuvant system 1 d after transfer of 105 Hy10 B cells and 5 × 
104 OT-II T cells (Green et al., 2011). Animals were analyzed 
at day 6 after immunization. For FTY720 experiments, mice 
were injected i.p. at 1 mg FTY720 (Selleck Chemicals) per kg 
body weight or an equivalent volume of saline for 3 h.
Retroviral constructs and transductions. The P2RY8 retro-
viral construct was made as described previously (Muppidi 
et al., 2014). Gpr183+/− spleen cells were harvested in media 
containing 0.25 µg/ml anti-CD180 (RP-105; clone RP14; 
BD) and cultured for 24  h. B cells heterozygous for EBI2 
(Gpr183) were used because the activation conditions used 
to retrovirally transduce the cells cause up-regulation of this 
receptor (contrary to its low expression in GC B cells), and 
we have found previously that EBI2 heterozygosity helps re-
veal the GC-clustering activity of S1pr2 (Green et al., 2011; 
Wang et al., 2011; Muppidi et al., 2014). The activated B 
cells were spin-infected twice on consecutive days for 1.5 h 
with retroviral supernatant and cultured overnight after the 
second spin infection before transfer into recipient mice. 
Transferred cells were analyzed after 24 h by flow cytometry 
and immunohistochemistry.
Cell isolation, clonality assessment, adoptive transfer, cell cul-
ture, treatments, flow cytometry, and qPCR. Cells from spleen, 
mLNs, and blood were isolated and stained as described pre-
viously (Green et al., 2011). Lymph was collected from the 
cisterna chyli via a fine glass micropipette (Matloubian et al., 
2004). Chemotaxis assays of GC B cells were performed using 
total mLN cells that were RBC lysed twice (Green et al., 2011). 
Flow cytometry was performed on an LSR II (BD). For GC B 
cell analysis, cells were stained with APC-Cy7–conjugated an-
ti-B220 (RA3-6B2; BioLegend), BV605-conjugated anti-CD4 
(RM4-5; BioLegend), Pacific blue–conjugated anti-IgD (11-
26c.2a; BioLegend), PE-Cy7–conjugated anti-CD38 (90; Bio-
Legend), PE-conjugated anti-Fas (Jo2; BD), AF647-conjugated 
anti-GL7 (GL7; BioLegend), FITC-conjugated anti-CD45.2 
(104; BioLegend), PerCP-Cy5.5–conjugated anti-CD45.1 
(A20; BioLegend), PerCP-Cy5.5–conjugated anti-CD86 (GL-
1; BioLegend), biotinylated anti-CXCR4 (2B11; BD), and/
or BV605 conjugated to streptavidin (BioLegend). qPCR 
was performed as described previously (Bannard et al., 2013) 
on FACS-sorted GC B cells. For human samples the follow-
ing primers were used: P2RY8, (F) 5′-TGT TTATT ACTTT 
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GCGTC CC-3′ and (R) 5′-ATC CCTTC AGGGT GCGC-3′; 
BCL6, (F) 5′-CGT GAGCA GTTTA GAGCC CA-3′ and (R) 
5′-GCA GAATC CCTCA GGGTT GA-3′; S1PR2, (F) 5′-
GGA CGCAG ACGCC AAGG-3′ and (R) 5′-CGA GTACA 
AGCTG CCCATG-3′; and PTP RC, (F) 5′-AAA CGGAG 
ATGCA GGGTC AA-3′ and (R) 5′-GTT TCATC CCTGG 
GACCT TGT-3′. For mouse samples the following primers 
were used: S1pr3, (F) 5′-GGA GCCCC TAGAC GGGAGT-3′ 
and (R) 5′-CCG ACTGC GGGAA GAGTGT-3′; and Ptprc, 
(F) 5′-TTC CAAGA GGAAG GAGCC CA-3′ and (R) 5′-
AGA ACAAC CCTGT CTGCT GG-3′.
Immunohistochemical analysis. Cryosections 7 µm in thick-
ness from mLNs and spleen were cut and prepared as de-
scribed previously (Green et al., 2011). Primary antibodies 
used for staining cryosections were biotinylated anti-Thy1.1 
(CD90.1; HIS51; eBioscience), biotinylated anti-GL7 (GL7; 
eBioscience), biotinylated or unlabeled anti-CD35 (8C12; 
BD), and unlabeled polyclonal goat anti–mouse IgD (Cedar-
lane). Secondary antibodies or streptavidin fused to alkaline 
phosphatase or peroxidase were from Jackson ImmunoRe-
search Laboratories, Inc. Images were captured with an Axio-
Observer Z1 inverted microscope (Carl Zeiss).
Image analysis. Single follicles were cropped from larger im-
ages using ImageJ (National Institutes of Health). The IHC 
Image Analysis Toolbox in ImageJ was used to create separate 
binary IgD and GL7 images of each follicle. Using MAT LAB, 
each pair of binary images was divided into 25-pixel by 25-
pixel boxes, and individual boxes were counted for pixels pos-
itive for IgD or GL7. Boxes containing no GL7 or IgD pixels 
were excluded. For remaining boxes, the proportion of pixels 
positive for GL7 was calculated by dividing the number of 
GL7-positive pixels by the sum of IgD- and GL7-positive 
pixels. The GC dispersal index, calculated in R, was defined as 
the fraction of boxes within each follicle containing between 
1 and 99% of pixels staining positive for GL7 (see Fig. S1 A 
for example of workflow). MAT LAB and R scripts are 
available upon request.
Statistical analysis. Prism software (GraphPad Software) was 
used for all statistical analysis. Data were analyzed with a 
two-sample unpaired (or paired, where indicated) Student’s t 
test. P-values were considered significant when ≤0.05.
Online supplemental material. Fig. S1 shows the workflow of 
quantification of GC dispersal from IHC images and pooled 
analysis of GC dispersal from all conditions analyzed. Online 
supplemental material is available at http ://www .jem .org /cgi 
/content /full /jem .20151250 /DC1.
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